EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma

Lisa Klaassen, Myriam G Jaarsma-Coes, Marina Marinkovic, Gregorius P M Luyten, Coen R N Rasch, Teresa A Ferreira, Jan-Willem M Beenakker

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.11.17 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Lisa Klaassen and 6 co-authors. Institution: Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands. Major MEDLINE topics: Uveal Neoplasms, Melanoma. Cited 3 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Purpose

Perfusion-weighted imaging (PWI; magnetic resonance imaging [MRI]) has been shown to provide valuable biological tumor information in uveal melanoma (UM). Clinically used semiquantitative methods do not account for tumor pigmentation and eye movement. We hypothesize that a quantitative PWI method that incorporates these, provides a more accurate description of tumor perfusion than the current clinical method. The aim of this study was to test this in patients with UM before and after radiotherapy.

Methods

Perfusion-weighted 3T MRIs were retrospectively analyzed in 47 patients with UM before and after radiotherapy. Tofts pharmacokinetic modeling was performed to determine vascular permeability (Ktrans), extracellular extravascular space (ve), and reflux rate (kep). These were compared with semiquantitative clinical parameters including peak intensity and outflow percentage.

Results

The effect of tumor pigmentation on peak intensity and outflow percentage was statistically significant (P < 0.01) and relative peak intensity was significantly different between melanotic and amelanotic tumors (1.5 vs. 1.9, P < 0.01). Before radiotherapy, median tumor Ktrans was 0.63 min-1 (range = 0.06-1.42 min-1), median ve was 0.23 (range = 0.09-0.63), and median kep was 2.3 min-1 (range = 0.6-5.0 min-1). After radiotherapy, 85% showed a decrease in Ktrans and kep (P < 0.01). Changes in tumor pigmentation before and after radiotherapy were small and not significant (median increase in T1 of 33 ms, P = 0.55).

Conclusions

Quantitative PWI parameters decreased significantly after radiotherapy and can therefore can serve as an early biomarker for treatment response assessment. However, due to the nonsignificant changes in tumor pigmentation before and after radiotherapy, the current semiquantitative method appears to be sufficiently sensitive for detection of changes in tumor perfusion.

Subjects

MeSH terms (MEDLINE)

Uveal NeoplasmsMelanomaHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultAged, 80 and overMagnetic Resonance AngiographyMagnetic Resonance ImagingUveal Melanoma

Authors and institutions

  • Leiden University Medical Center, Department of Ophthalmology, Leiden, The Netherlands.
  • Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands.
  • Leiden University Medical Center, Department of Radiation Oncology, Leiden, The Netherlands.
  • HollandPTC, Delft, The Netherlands.

Cite

APA

Klaassen, L., Jaarsma-Coes, M. G., Marinkovic, M., Luyten, G. P. M., Rasch, C. R. N., Ferreira, T. A., & Beenakker, J. M. (2024). Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.11.17

Vancouver

Klaassen L, Jaarsma-Coes MG, Marinkovic M, Luyten GPM, Rasch CRN, Ferreira TA, et al. Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.11.17

BibTeX
@article{Klaassen2024,
  author = {Klaassen, Lisa and Jaarsma-Coes, Myriam G and Marinkovic, Marina and Luyten, Gregorius P M and Rasch, Coen R N and Ferreira, Teresa A and Beenakker, Jan-Willem M},
  title = {Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.11.17}
}
Start for free →